Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Perspective Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$121.18M. For fiscal 2025 it was -$110.31M. The highest annual figure on record is -$2.07M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$110.31M | – |
| FY2024 | Dec 31, 2024 | -$88.58M | – |
| FY2017 | Jun 30, 2017 | -$6.24M | – |
| FY2016 | Jun 30, 2016 | -$4.61M | – |
| FY2015 | Jun 30, 2015 | -$3.76M | – |
| FY2014 | Jun 30, 2014 | -$3.90M | – |
| FY2013 | Jun 30, 2013 | -$3.33M | – |
| FY2012 | Jun 30, 2012 | -$2.75M | – |
| FY2011 | Jun 30, 2011 | -$2.07M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$28.12M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$27.16M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$38.82M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$27.09M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$23.31M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$21.10M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$44.28M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$17.97M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$13.69M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$12.65M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$2.03M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$1.30M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$1.85M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$1.37M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$1.46M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$1.56M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$1.20M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$1.19M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$1.27M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$954.00K | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$967.79K | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$916.94K | – |
See a number that looks wrong?